Literature DB >> 12899235

A life-threatening infection: Fournier's gangrene.

Irfan Huseyin Atakan1, Mustafa Kaplan, Esat Kaya, Tevfik Aktoz, Osman Inci.   

Abstract

Fournier's gangrene is a life-threatening disorder in which infection of the perineum and scrotum spreads along fascial planes, causing soft tissue necrosis. If urgent surgery is delayed, the disease will soon result in septic shock, multiorgan failure, and death. In this study, we present 21 patients with Fournier's gangrene who were treated in period between 1994 and 2001. Patients' charts were reviewed retrospectively and are discussed in the light of literature. All patients received aggressive surgical debridment. Penicillin or Ceftriaxone, aminoglicoside and metronidazole were administered intravenously. Of the 21 patients, 5 had scrotal carbuncle, 1 had urethral stricture, 1 had chronic indwelling urethral catheterization, 2 had perirectal abscess, and 1 had hemorrhoidectomy. In eleven patients we couldn't identify any cause. Twelve patients had diabetes mellitus, and two had chronic alcoholism. Escherichia coli was isolated in 12 purulent tissue cultures, and Bacteroides fragilis in eight. Seventeen patients survived, whereas four died. Fourier's gangrene is considered a surgical emergency. Early surgical intervention is essential, as the gangrene can spread rapidly at rates reaching 2 mm per hour. So that Fournier's gangrene is an abrupt, rapidly progressive, gangrenous infection of the external genitalia and perineum and is a real urologic emergency.

Entities:  

Mesh:

Year:  2002        PMID: 12899235     DOI: 10.1023/a:1024427418743

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Air on radiography of perineal necrotizing fasciitis indicates testis involvement.

Authors:  J Rehman; A Kaynan; D Samadi; J Fleischmann
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

2.  Hyperbaric oxygen therapy in the treatment of Fournier's disease in 11 male patients.

Authors:  R Pizzorno; F Bonini; A Donelli; R Stubinski; M Medica; G Carmignani
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

3.  The continuing challenge of Fournier's gangrene in the 1990s.

Authors:  J N Olsofka; E H Carrillo; D A Spain; H C Polk
Journal:  Am Surg       Date:  1999-12       Impact factor: 0.688

4.  Fournier's gangrene with an unusual urologic etiology.

Authors:  J M Fialkov; K Watkins; B Fallon; G P Kealey
Journal:  Urology       Date:  1998-08       Impact factor: 2.649

5.  Fournier's gangrene: an unusual presentation for rectal carcinoma.

Authors:  R A Gamagami; M Mostafavi; A Gamagami; F Lazorthes
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

6.  Minimal debridement in the treatment of Fournier's gangrene.

Authors:  E E Frezza; I Atlas
Journal:  Am Surg       Date:  1999-11       Impact factor: 0.688

Review 7.  Fournier's gangrene: a review of 1726 cases.

Authors:  N Eke
Journal:  Br J Surg       Date:  2000-06       Impact factor: 6.939

8.  Fournier's gangrene: review of fifteen cases.

Authors:  M Başoğlu; O Gül; I Yildirgan; A A Balik; I Ozbey; D Oren
Journal:  Am Surg       Date:  1997-11       Impact factor: 0.688

9.  A case of Fournier gangrene complicating idiopathic nephrotic syndrome of childhood.

Authors:  A J Wright; A Lall; W R Gransden; M R Joyce; A Rowsell; G Clark
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

10.  Fournier's gangrene: risk assessment and enzymatic debridement with lyophilized collagenase application.

Authors:  R Aşci; S Sarikaya; R Büyükalpelli; A F Yilmaz; S Yildiz
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

View more
  9 in total

1.  Evaluation of factors affecting mortality in Fournier's Gangrene: Retrospective clinical study of sixteen cases.

Authors:  Erkan Oymacı; Ali Coşkun; Savaş Yakan; Nazif Erkan; Ahmet Deniz Uçar; Mehmet Yıldırım
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

2.  Co-operative inhibitory effects of hydrogen peroxide and iodine against bacterial and yeast species.

Authors:  Elena I Zubko; Mikhajlo K Zubko
Journal:  BMC Res Notes       Date:  2013-07-15

3.  Fournier's gangrene: an analysis of 80 patients and a novel scoring system.

Authors:  T Yilmazlar; E Ozturk; H Ozguc; I Ercan; H Vuruskan; B Oktay
Journal:  Tech Coloproctol       Date:  2010-06-18       Impact factor: 3.781

Review 4.  Fournier's gangrene: exists and it is still lethal.

Authors:  M Safioleas; M Stamatakos; G Mouzopoulos; A Diab; K Kontzoglou; A Papachristodoulou
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

5.  Fournier's Gangrene after Open Hemorrhoidectomy without a Predisposing Factor: Report of a Case and Review of the Literature.

Authors:  Guldeniz Karadeniz Cakmak; Oktay Irkorucu; Bulent H Ucan; Kemal Karakaya
Journal:  Case Rep Gastroenterol       Date:  2009-05-15

6.  New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients.

Authors:  R Czymek; P Hildebrand; M Kleemann; U Roblick; M Hoffmann; T Jungbluth; C Bürk; H-P Bruch; P Kujath
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

7.  Hyperbaric oxygen therapy decreases mortality due to Fournier's gangrene: a retrospective comparative study.

Authors:  Omar Feres; Marley Ribeiro Feitosa; José Joaquim Ribeiro da Rocha; Juliana Mamede Miranda; Luciana Egydio Dos Santos; Artur Cury Féres; Hugo Parra de Camargo; Rogério Serafim Parra
Journal:  Med Gas Res       Date:  2021 Jan-Mar

8.  Is hemoglobin A1c level effective in predicting the prognosis of Fournier gangrene?

Authors:  Haluk Sen; Omer Bayrak; Sakip Erturhan; Ersin Borazan; Mustafa Nihat Koc
Journal:  Urol Ann       Date:  2016 Jul-Sep

9.  Risk factors for mortality in fournier's gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI).

Authors:  Carlos Eugênio Lira Tenório; Salvador Vilar Correia Lima; Amanda Vasconcelos de Albuquerque; Mariana Pauferro Cavalcanti; Flávio Teles
Journal:  Int Braz J Urol       Date:  2018 Jan-Feb       Impact factor: 1.541

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.